Work

Assessment of Minimal Residual Disease in a Phase 1b Study of Once-Weekly Carfilzomib Combined with Lenalidomide and Dexamethasone in Patients with Multiple Myeloma

Year: 2020

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2020-133803

Authors: Ola Landgren, Melissa Alsina, Noa Biran, David H. Vesole, Paul K. Wallace, Belle Fang, Gregory Arnold, Amy Kimball, David S. Siegel

Institutions: Memorial Sloan Kettering Cancer Center, Moffitt Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, Roswell Park Comprehensive Cancer Center, Amgen (United States)

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3094792334

Cites:

Cited by:

Related to: 10